<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260604069641N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-24</date_registration>
      <primary_sponsor>University of Science and Art, Yazd, Iran</primary_sponsor>
      <public_title>Comparison of psychological treatments for OCD</public_title>
      <acronym></acronym>
      <scientific_title>comparative examination of mindfulness‑based compassion therapy and eye movement desensitization and reprocessing therapy with pharmacological control on emotion regulation, psychological adjustment, and anxiety in patients with obsessive–compulsive disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90631</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be assigned to one of three groups—Mindfulness-Based Compassion Therapy (MBCT), Eye Movement Desensitization and Reprocessing (EMDR), or the control group—using a simple randomization method, with individual participants serving as the unit of randomization. To generate the allocation sequence, a series of random numbers will be produced using the random number generator function in SPSS (version 26.0).
Allocation will be based on the generated numbers: numbers assigned to the MBCT group will be designated as ‘1’, numbers for the EMDR group as ‘2’, and numbers for the control group as ‘3’. To ensure strict allocation concealment, this sequence will be managed by an independent researcher who will have no involvement in the recruitment, clinical assessment, or treatment delivery.
Prior to the start of the study, the independent researcher will prepare sequentially numbered, opaque, and sealed envelopes, each containing the group assignment (1, 2, or 3) based on the pre-generated random sequence. Upon enrollment and after obtaining written informed consent, the researcher/assessor will open the next available envelope in the sequence and assign the participant to the corresponding group, Blinding description: This study is conducted in a single-blind manner. Questionnaires are recorded with anonymous codes and delivered to the outcome assessor and data analyst.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obsessions and compulsions.</hc_freetext>
      <i_freetext>Intervention 1: "Intervention group1:" The primary intervention is based on the Mindfulness-Based Compassion Training protocol, adapted from the model by Pirzad et al. (2024). This intervention will be conducted in eight weekly 90-minute sessions at the Armana Clinic in Yazd. Session 1: Introduction to Obsessive-Compulsive Disorder (OCD), mindfulness, and self-compassion, focusing on their role in reducing hopelessness. Exercises include breathing awareness and non-judgmental observation of obsessive thoughts. Session 2: Distinguishing between “thoughts,” “emotions,” and “obsessive behaviors,” emphasizing non-reactive observation. Practice of body scan with a compassionate approach toward unpleasant experiences. Session 3: Identifying difficult emotions associated with OCD (anxiety, shame, hopelessness) and fostering acceptance. Exercises focus on compassion-focused breathing and cultivating a sense of safety when facing threatening emotions. Session 4: Examining the role of self-blame and self-criticism in the maintenance of OCD. Practice of compassionate self-talk in response to obsessive thoughts and perceived mistakes. Session 5: Training in compassionate responses to obsessive thoughts as an alternative to avoidance or struggle. Exercises in experiencing acceptance with kindness, without the urge for immediate control. Session 6: Training in emotion regulation strategies based on the mindfulness and self-compassion model. Session 7: Practicing the “Mindful Pause” in OCD-triggering situations. Application of mindfulness and compassion to daily life challenges and OCD symptoms. Session 8: Mindful exposure to obsessive thoughts while maintaining a compassionate attitude. Review of acquired skills and the role of self-compassion in reducing hopelessness and enhancing psychological adjustment. Development of a personalized self-care and mindfulness plan for relapse prevention and sustained improvement.The therapeutic process is structured across eight distinct sessions, each carefully sequenced to build upon the foundational knowledge and skills established in preceding sessions. This hierarchical progression ensures that clients are adequately prepared and resourced at each stage, facilitating a systematic and cumulative approach to achieving therapeutic objectives. Intervention 2: "Intervention group 2:" The second intervention is based on the Eye Movement Desensitization and Reprocessing (EMDR) protocol, adapted from the model by Dreessen et al. (2024). This intervention will be implemented weekly in eight 45-minute sessions at the Armana Clinic in Yazd. Phase 1 (History Taking and Treatment Planning): Gathering baseline information, including family history, clinical background, current symptomatology, and the client’s existing social support system. Phase 2 (Preparation): Educating and preparing the client for processing traumatic memories. This phase involves teaching coping skills, pain management techniques, and relaxation exercises to be practiced between sessions. Phase 3 (Assessment): Identifying the target memory, selecting a negative cognition (NC), and establishing a positive cognition (PC). The client’s Subjective Units of Disturbance (SUD) scale and Validity of Cognition (VoC) scale are assessed and recorded. Phase 4 (Desensitization): The client focuses on the distressing image, negative beliefs, and associated physical sensations while receiving bilateral stimulation (BLS) through eye movements. This process continues until the intensity of the distress is reduced to a manageable level. Phase 5 (Installation): The goal is to strengthen the positive cognition and replace the negative belief associated with the traumatic memory with a more adaptive, positive one. Phase 6 (Body Scan): The client performs a head-to-toe body scan to identify any remaining physical tension. Bilateral stimulation is utilized to process and release these somatic sensations, fostering a sense of relief and well-being. Phase 7 (Closure): The client reflects on their current emotional and cognitive state. The therapist ensures the client ends the session in a stable and balanced state. Phase 8 (Re-evaluation): Reviewing treatment goals, conducting a follow-up assessment of the client’s progress, and concluding the therapy process.The therapeutic process is structured across eight distinct sessions, each carefully sequenced to build upon the foundational knowledge and skills established in preceding sessions. This hierarchical progression ensures that clients are adequately prepared and resourced at each stage, facilitating a systematic and cumulative approach to achieving therapeutic objectives. Intervention 3: Control group: will receive no therapeutic intervention during the study period, serving as a baseline for comparison with the experimental group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is To protect the privacy and confidentiality of the participants, raw individual-level data (IPD) will not be shared publicly. The study adheres to strict ethical guidelines regarding data protection to ensure that no participant can be identified from the shared information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sepideh Semsar Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.6, Alley 8, Amir Kabir Blvd, University Town,Yazd,Iran</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8916147164</zip>
        <telephone>+98 35 3821 2747</telephone>
        <email>sepidehsemsaryazdi@gmail.com</email>
        <affiliation>University of Science and Art, Yazd, Iran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Mohsen Saeidmanesh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Armana Psychology Clinic, Hazrat Abbas St., Jomhouri Eslami Blvd., Yazd, Iran.</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8917945730</zip>
        <telephone>+98 35 3530 4351</telephone>
        <email>m.saeidmanesh@yahoo.com</email>
        <affiliation>University of Science and Art, Yazd, Iran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Suffering from obsessive-compulsive disorder (OCD)
OCD of the type of contamination, washing and checking
Treatment started less than six months ago in the sample
Having minimum reading and writing skills to answer questionnaire questions
Receive fixed drug treatment (Asentra 100 mg)
Availability to fully attend therapy sessions</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of psychotic or bipolar disorders
History of suicide attempt in the last 6 months
Receiving other structured psychotherapy at the same time
Starting, stopping, or changing the dose of psychiatric medication within 8 weeks prior to study entry
Presence of severe learning disabilities or neurological disorders
Drug use or alcohol dependence in the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F42</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obsessive-compulsive disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>"Intervention group1:" The primary intervention is based on the Mindfulness-Based Compassion Training protocol, adapted from the model by Pirzad et al. (2024). This intervention will be conducted in eight weekly 90-minute sessions at the Armana Clinic in Yazd. Session 1: Introduction to Obsessive-Compulsive Disorder (OCD), mindfulness, and self-compassion, focusing on their role in reducing hopelessness. Exercises include breathing awareness and non-judgmental observation of obsessive thoughts. Session 2: Distinguishing between “thoughts,” “emotions,” and “obsessive behaviors,” emphasizing non-reactive observation. Practice of body scan with a compassionate approach toward unpleasant experiences. Session 3: Identifying difficult emotions associated with OCD (anxiety, shame, hopelessness) and fostering acceptance. Exercises focus on compassion-focused breathing and cultivating a sense of safety when facing threatening emotions. Session 4: Examining the role of self-blame and self-criticism in the maintenance of OCD. Practice of compassionate self-talk in response to obsessive thoughts and perceived mistakes. Session 5: Training in compassionate responses to obsessive thoughts as an alternative to avoidance or struggle. Exercises in experiencing acceptance with kindness, without the urge for immediate control. Session 6: Training in emotion regulation strategies based on the mindfulness and self-compassion model. Session 7: Practicing the “Mindful Pause” in OCD-triggering situations. Application of mindfulness and compassion to daily life challenges and OCD symptoms. Session 8: Mindful exposure to obsessive thoughts while maintaining a compassionate attitude. Review of acquired skills and the role of self-compassion in reducing hopelessness and enhancing psychological adjustment. Development of a personalized self-care and mindfulness plan for relapse prevention and sustained improvement.The therapeutic process is structured across eight distinct sessions, each carefully sequenced to build upon the foundational knowledge and skills established in preceding sessions. This hierarchical progression ensures that clients are adequately prepared and resourced at each stage, facilitating a systematic and cumulative approach to achieving therapeutic objectives.</i_keyword>
      <i_keyword>"Intervention group 2:" The second intervention is based on the Eye Movement Desensitization and Reprocessing (EMDR) protocol, adapted from the model by Dreessen et al. (2024). This intervention will be implemented weekly in eight 45-minute sessions at the Armana Clinic in Yazd. Phase 1 (History Taking and Treatment Planning): Gathering baseline information, including family history, clinical background, current symptomatology, and the client’s existing social support system. Phase 2 (Preparation): Educating and preparing the client for processing traumatic memories. This phase involves teaching coping skills, pain management techniques, and relaxation exercises to be practiced between sessions. Phase 3 (Assessment): Identifying the target memory, selecting a negative cognition (NC), and establishing a positive cognition (PC). The client’s Subjective Units of Disturbance (SUD) scale and Validity of Cognition (VoC) scale are assessed and recorded. Phase 4 (Desensitization): The client focuses on the distressing image, negative beliefs, and associated physical sensations while receiving bilateral stimulation (BLS) through eye movements. This process continues until the intensity of the distress is reduced to a manageable level. Phase 5 (Installation): The goal is to strengthen the positive cognition and replace the negative belief associated with the traumatic memory with a more adaptive, positive one. Phase 6 (Body Scan): The client performs a head-to-toe body scan to identify any remaining physical tension. Bilateral stimulation is utilized to process and release these somatic sensations, fostering a sense of relief and well-being. Phase 7 (Closure): The client reflects on their current emotional and cognitive state. The therapist ensures the client ends the session in a stable and balanced state. Phase 8 (Re-evaluation): Reviewing treatment goals, conducting a follow-up assessment of the client’s progress, and concluding the therapy process.The therapeutic process is structured across eight distinct sessions, each carefully sequenced to build upon the foundational knowledge and skills established in preceding sessions. This hierarchical progression ensures that clients are adequately prepared and resourced at each stage, facilitating a systematic and cumulative approach to achieving therapeutic objectives.</i_keyword>
      <i_keyword>Control group: will receive no therapeutic intervention during the study period, serving as a baseline for comparison with the experimental group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of obsessive-compulsive symptoms (OCD). Timepoint: Pre-intervention, immediately post-intervention, and 4 weeks post-intervention. Method of measurement: Clinical Assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: Pre-intervention, immediately post-intervention, and 4 weeks post-intervention. Method of measurement: Beck Anxiety Inventory(Beck et al.,1990).</sec_outcome>
      <sec_outcome>Psychological adjustment. Timepoint: Pre-intervention, immediately post-intervention, and 4 weeks post-intervention. Method of measurement: Bell Adjustment Inventory(1961).</sec_outcome>
      <sec_outcome>Emotion regulation. Timepoint: Pre-intervention, immediately post-intervention, and 4 weeks post-intervention. Method of measurement: Emotion Regulation Questionnaire(Gross &amp; John,2003).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Science and Art, Yazd, Iran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-09</approval_date>
        <contact_name>Ethics committee of University of Science and Culture, Jihad Daneshgahi</contact_name>
        <contact_address>Bahar Ave., Shahid Ghamoshi., Ashrafi Esfahani Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
